U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
131251131251Newborn Screening for Severe Combined Immunodeficiency (SCID) in a High-Risk PopulationCompletedNo Results AvailableSevere Combined Immunodeficiency|T Cell Lymphocytopeniahttps://ClinicalTrials.gov/show/NCT00845416
131252131252Antigen-specific Immune Response to Hepatitis B Virus in UteroRecruitingNo Results AvailableHepatitis Bhttps://ClinicalTrials.gov/show/NCT00845403
131253131253Patient Expectations After Implantable-cardioverter Defibrillator (ICD) ImplantationCompletedNo Results AvailableDefibrillators, Implantablehttps://ClinicalTrials.gov/show/NCT00845390
131254131254Changing Minds - Supporting Depressed Elderly People With an Individually Tailored Service ModelRecruitingNo Results AvailableDepression|Psychological Well-BeingBehavioral: Comprehensive psychosocial support for depressed elderlyhttps://ClinicalTrials.gov/show/NCT00845377
131255131255Metabolic Support With Perhexiline to Protect Myocardium Undergoing Coronary Artery SurgeryCompletedNo Results AvailableMyocardial Reperfusion Injury|Cardiac Output, LowDrug: Perhexiline|Drug: Placebo marked PEXSIGhttps://ClinicalTrials.gov/show/NCT00845364
131256131256Preoperative Bexarotene Treatment for Cushing's DiseaseRecruitingNo Results AvailableCushing's DiseaseDrug: Bexarotenehttps://ClinicalTrials.gov/show/NCT00845351
131257131257Study of Darifenacin in Patients Suffering From Multiple Sclerosis and Neurogenic Detrusor OveractivityTerminatedNo Results AvailableMultiple Sclerosis|Overactive DetrusorDrug: Darifenacin (BAY79-4998)https://ClinicalTrials.gov/show/NCT00845338
131258131258Early Motion Following Carpal Tunnel ReleaseRecruitingNo Results AvailableCarpal Tunnel SyndromeBehavioral: Group One|Behavioral: Control Group Twohttps://ClinicalTrials.gov/show/NCT00845325
131259131259Prognostic Features for Mortality in Young Adults With PneumoniaCompletedNo Results AvailablePneumoniahttps://ClinicalTrials.gov/show/NCT00845312
131260131260Study of the Effects of Artificial Tears on the Response to the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle GlaucomaCompletedNo Results AvailableGlaucoma|Ocular HypertensionDrug: Latanoprost punctal plug|Drug: artificial tears preserved with Benzalkonium Chloridehttps://ClinicalTrials.gov/show/NCT00845299
131261131261Marathon, Genetics, Inflammation and the Cardiovascular System: MAGIC-TrialRecruitingNo Results AvailableHeart Failure|Sudden Cardiac DeathBehavioral: Munich Marathonhttps://ClinicalTrials.gov/show/NCT00845286
131262131262Long-Term Use Of Pegaptanib In Patients For Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular DegenerationCompletedNo Results AvailableMacular DegenerationDrug: Pegaptanib sodiumhttps://ClinicalTrials.gov/show/NCT00845273
131263131263Internet-Versus Group-Administered Cognitive Behavior Therapy for Panic DisorderCompletedNo Results AvailablePanic DisorderBehavioral: Internet-based cognitive behavior therapy (CBT).|Behavioral: Group CBThttps://ClinicalTrials.gov/show/NCT00845260
131264131264The Effect of Case Management in Complex Cancer PathwaysCompletedNo Results AvailableColonic Neoplasms|Rectal NeoplasmsOther: Nurse case managementhttps://ClinicalTrials.gov/show/NCT00845247
131265131265Establishing a Standard for Peri-operative Implantable Cardioverter Defibrillator (ICD) Patient EducationCompletedNo Results AvailableArrhythmiaBehavioral: Interventionhttps://ClinicalTrials.gov/show/NCT00845234
131266131266Glivec in Pediatric Chronic Myeloid Leukemia (CML)Active, not recruitingNo Results AvailableChronic Myeloid LeukemiaDrug: Imatinib mesylate 100 mg (Glivec)https://ClinicalTrials.gov/show/NCT00845221
131267131267Network Support for Treatment of Alcohol DependenceCompletedNo Results AvailableAlcohol DependenceBehavioral: Network Supporthttps://ClinicalTrials.gov/show/NCT00845208
131268131268Comparison of Seasonal Allergic Rhinitis Treatment With 2 Antihistamines Used in Combination With Intranasal CorticosteroidCompletedHas ResultsSeasonal Allergic RhinitisDrug: Olopatadine HCl Nasal Spray, 0.6%|Drug: Azelastine HCl Nasal Spray, 0.1%https://ClinicalTrials.gov/show/NCT00845195
131269131269Effect of Pioglitazone and Exenatide on Body Weight and Beta Cell FunctionCompletedHas ResultsType 2 Diabetes|Healthy|Impaired Glucose ToleranceDrug: Pioglitazone|Drug: Exenatide|Drug: Pioglitazone and Exenatidehttps://ClinicalTrials.gov/show/NCT00845182
131270131270The Role of Nitric Oxide Synthase Isoforms in the Cardiovascular Effects of Air PollutionCompletedNo Results AvailableEndothelial DysfunctionProcedure: Forearm vascular studyhttps://ClinicalTrials.gov/show/NCT00845169
131271131271Alpha Lipoic Acid and Insulin ResistanceCompletedNo Results AvailableInsulin ResistanceDietary Supplement: Alpha Lipoic Acidhttps://ClinicalTrials.gov/show/NCT00845156
131272131272Vibration Response Imaging (VRI) in the Preoperative Management in Patients With Non-Small Cell Lung CancerActive, not recruitingNo Results AvailableNon-Small Cell Lung Cancer|Lung Functionhttps://ClinicalTrials.gov/show/NCT00845143
131273131273Quantitative in Vivo Biomarkers of Oxidative Stress in DiabetesCompletedNo Results AvailableType 2 Diabetes|Oxidative StressBiological: ascorbic acid (Vitamin C)https://ClinicalTrials.gov/show/NCT00845130
131274131274Cultivated Stem Cell Transplantation for the Treatment of Limbal Stem Cell DeficiencyActive, not recruitingNo Results AvailableLimbal Stem Cell DeficiencyProcedure: Cultivated limbal stem cell graft transplantationhttps://ClinicalTrials.gov/show/NCT00845117
131275131275Fludarabine Phosphate, Rituximab, and Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Relapsed or Not Responded To TreatmentWithdrawnNo Results AvailableB-cell Chronic Lymphocytic Leukemia|Refractory Chronic Lymphocytic LeukemiaDrug: fludarabine phosphate|Biological: rituximab|Biological: bevacizumab|Other: laboratory biomarker analysis|Other: flow cytometry|Genetic: polymerase chain reaction|Genetic: fluorescence in situ hybridizationhttps://ClinicalTrials.gov/show/NCT00845104
131276131276Cardiac Autonomic Regulation Enhancement Through Exercise TrialCompletedNo Results AvailableCardiovascular Disease, ArrhythmiasBehavioral: Exercise|Behavioral: Heart Healthy Educationhttps://ClinicalTrials.gov/show/NCT00845091
131277131277Prospective Outcomes After Reconstruction and Radiotherapy for Breast CancerRecruitingNo Results AvailableBreast|Radiotherapy|Aesthetics|Treatment Outcome|Surgical Reconstructionhttps://ClinicalTrials.gov/show/NCT00845078
131278131278Boceprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Participants With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin (Study P05685AM2)(COMPLETED)CompletedHas ResultsHepatitis C, ChronicDrug: Boceprevir|Other: Placebo|Biological: Peginterferon alfa-2a|Drug: Ribavirinhttps://ClinicalTrials.gov/show/NCT00845065
131279131279Survey of Housestaff Attitudes Toward Patient Care and SafetyCompletedNo Results AvailableSafety.|Patient Carehttps://ClinicalTrials.gov/show/NCT00845052
131280131280A Study of Irinotecan and Cetuximab With or Without IMC-A12 for Treatment of People With Colon or Rectum Cancer Who Got Worse After Their First Treatment With Oxaliplatin and BevacizumabCompletedNo Results AvailableColon Cancer|Rectal CancerBiological: Cetuximab|Drug: Irinotecan|Biological: IMC-A12 (cixutumumab)https://ClinicalTrials.gov/show/NCT00845039

* Görseller ve İçerik tekif hakkına sahip olabilir